April - 2021
| Previous Past Months | Showing Journal 3 of 3 |
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure The HENIVOT Randomized Clinical TrialD Grieco, L Menga, M Cesarano, et al for the COVID-ICU Gemelli Study Group JAMA, 2021, March 2021 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
April |
Previous Comments
No Comments yet.
Comment
The HENIVOT set out to compare the effect of early continuous treatment with helmet noninvasive ventilation to high-flow nasal oxygen, on the number of days free of respiratory support at 28 days, in adult patients admitted to ICU with COVID-19–induced...